Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Potential of Kava in Enabling Tobacco Cessation
NCT05814055Phase 2Recruiting
- Sponsor
- University of Florida
- Start
- Jun 2024
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Tobacco Use Disorder (TUD) comparing AB-free kava with Placebo control (2 arms). Primary endpoint: Subject Compliance with Intervention at 4 weeks. Started Jun 2024; status: recruiting.
02
Drugs
kava
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT05814055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05814055.